EN DE

Zepp Health Corporation (ZEPP) Fair Value & Analysis

Technology · US · Market cap $65.3M

ZH Zepp Health Corporation logo Zepp Health Corporation ZEPP · US
Price$4.75
Fair Value$7.06
Upside+48.7%
Quality55/100
Watch Zepp Health Corporation for free, get notified when fair value or trend changes. Watch for free
Weak Growth
Loss-making · -14.7% net margin
Low debt · negative free cash flow
Mixed vs. peers (4/9)
Narrow moat 12/100
Evidence: Low Range $5.27 – $10.54 Share as image

Fair value as of: Jul 25, 2026

From 1 valuation models · updated 16 days ago

Fair value updated Jul 25, 2026, revised from $7.22 to $7.06 (−2.1%) since Jun 25, 2026. Share price −7.2% over the past month.

A solid business, screening 49% undervalued on our models.

What matters now

  • The price is below even our cautious bear case ($5.27). The market is more pessimistic than our downside scenario.
  • The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
  • Solid quality (55/100) at a price below fair value, the discount is the argument here, not the business quality.
  • A fairly wide model range ($5.27 to $10.54) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$61.27 $2.06 Fair Value $7.06 Apr 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 25, 2026.

How to read this chart

60‑month range $2.06 – $61.27 · fair‑value band $5.27 – $10.54 · the $4.75 price screens below the $7.06 fair value. Dashed = 300-day average. As of Jul 25, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Zepp Health Corporation (ZEPP) currently trades at $4.75, while our model-based Fair Value estimate is $7.06, implying the stock looks roughly 48.7% undervalued today. The Quality Score stands at 55/100 (solid quality), in the Technology sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.

Over the trailing twelve months, Zepp Health Corporation generated revenue of $272M at a net margin of -14.7%. Revenue grew 33.8% year over year. It earns a return on equity of -18.8%. Net debt stands at $805M. Fundamentals as of Jul 25, 2026

Our scenario range runs from $5.27 (bear case) to $10.54 (bull case); at $4.75, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Technology peers we cover trades at -16% fair-value upside, at 49%, ZEPP screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
NCAV (Graham) $88.66 $118.80 $177.32 50
All 1 models by family
Asset-Based
NCAV (Graham) $88.66 $118.80 $177.32 50

Notify me when ZEPP reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) $272M
Revenue growth (YoY) +33.8%
Net margin -14.7%
Return on equity -18.8%
Free cash flow −$185M FY2025
Operating margin -33.9%
More key figures
EPS (TTM) $-2.56
EPS growth (YoY) -68.1%
Net debt $805M FY2025

Figures from reported company fundamentals · as of Jul 25, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 55/100

Of which business quality 51 · Market factors (momentum, volatility) 1

Profitability 12
Margins and returns on capital today
Quality Growth 92
Are margins and returns improving?
Cashflow 3
Earnings quality: real cash, not paper profit
Fin. Strength 53
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 1
Calm price path (market factor)
Momentum 0
Price trend over the last 3–12 months (market factor)
52W Momentum 2
Distance to the 52-week high (market factor)
Net Issuance 100
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.

Full company description

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company offers smart bands, smart watches, smart rings, hearables, the Helio Strap, smart scales, and accessories; and sportswear, home appliances, and smart watch accessories. It also provides Zepp Aura, a real-time, personalized sound health solution offering health management, including emotional regulation and sports performance optimization; and provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. The company offers its products under the Amazfit and Zepp brand names in approximately 90 countries. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is based in Gorinchem, The Netherlands.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Zepp Health Corporation reported revenue of $1.8B in FY2025 versus $6.2B in FY2021, a compound −26.4%/yr. Reported net income was −$281M in FY2025.

Growth Quality 6/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2025)
$1.8B
Latest YoY
+36.1%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−24.5%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−21.5%
Avg. growth/yr (10Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+7.0%
Revenue −26.4%/yr
FY21 $6.2B
FY22 $4.2B
FY23 $2.5B
FY24 $1.3B
FY25 $1.8B
Net income
FY21 $136M
FY22 −$293M
FY23 −$220M
FY24 −$554M
FY25 −$281M

Watch ZEPP: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Zepp Health Corporation Fair Value". https://www.fairvalue-calculator.com/stock/ZEPP

Peer Group

Consumer Electronics · 129 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 51 · Below median
Fair Value upside +49% · Top 25%
Return on assets -3% · Bottom 25%
Net margin (TTM) -15% · Bottom 25%
Operating margin (TTM) -34% · Bottom 25%
Revenue growth 34% · Top 25%
Debt / equity 0.04× · Lower than median

Valuation Multiples vs Consumer Electronics median · lower = cheaper

P/S (TTM) 0.24× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 98 · sector 8
FUTURE 100 · sector 13
PAST 0 · sector 10
HEALTH 98 · sector 97
DIVIDEND 0 · sector 29

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Consumer Electronics stocks, each showing price versus our Fair Value estimate (as of Jul 25, 2026).

Stock Price Fair Value vs Fair Value
Apple Inc AAPL $313.33 $122.91 -61%
Samsung Electronics Co 005930 255,000 KRW 138,019 KRW -46%
Sony Group SONYN 366.00 MXN 468.94 MXN +28%
Xiaomi Corporation 1810 HK$26.88 HK$39.84 +48%
LG Electronics Inc 066570 179,000 KRW 101,531 KRW -43%
Sharetronic Data Technology Co 300857 ¥277.96 ¥35.89 -87%
Huaqin Co 603296 ¥78.20 ¥65.69 -16%
Goertek Inc 002241 ¥22.25 ¥18.86 -15%
LG Corp 003550 102,400 KRW 93,881 KRW -8%
Anker Innovations Limited 300866 ¥105.92 ¥78.52 -26%

Compare Zepp Health Corporation with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Zepp Health Corporation (ZEPP) overvalued or undervalued?
As of Jul 25, 2026, our model estimates a fair value of $7.06 versus a price of $4.75, about +49% (undervalued).
What is the fair value of ZEPP?
Our model-based fair value for Zepp Health Corporation is $7.06 (as of Jul 25, 2026), built from audited fundamentals. The current price is $4.75.
What is the quality score of ZEPP?
Zepp Health Corporation has a Quality Score of 55/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Zepp Health Corporation (ZEPP)?
Zepp Health Corporation reported trailing-twelve-month revenue of about $272M (latest available figure, as of Jul 25, 2026).
What is the net profit margin of ZEPP?
The net profit margin of Zepp Health Corporation is about -14.7%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Zepp Health Corporation and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.